Skip to main content
. 2023 Feb 1;117(4):717–730. doi: 10.1016/j.ajcnut.2023.01.018

TABLE 1.

Characteristics of study participants, collected at baseline1

Characteristic Participants included (n = 34) Participants not included (n = 72) P
Age, y2 46.8 ± 11.2 47.0 ± 12.3 0.93
Female, n (%)2 23 (67.7) 58 (80.6) 0.14
Race/ethnicity (self-identified), n (%)
 Non-Hispanic White 6 (17.7) 13 (18.1) 0.74
 African American 19 (55.9) 39 (54.2)
 Asian/Pacific Islander 0 (0.0) 2 (2.8)
 Hispanic 6 (17.7) 15 (20.8)
 Other (e.g., decline to state, multirace) 3 (8.8) 3 (4.2)
Education, n (%)
 High school/GED or less 5 (14.7) 9 (12.5) 0.78
 College - 1 y – 3 y 13 (38.2) 30 (41.7)
 College - 4 y or more 11 (32.4) 18 (25.0)
 Postcollege 5 (14.7) 15 (20.8)
Income, n (%)
 <$35,000 13 (38.2) 21 (29.2) 0.36
 $35,000 to <$55,000 8 (23.5) 18 (25.0)
 $55,000 to <$75,000 2 (5.9) 13 (18.1)
 ≥$75,000 11 (32.4) 20 (27.8)
BMI, kg/m2 36.6 ± 6.2 37.3 ± 6.0 0.57
Weight, kg 101.3 ± 13.3 101.6 ± 16.1 0.93
Waist circumference, cm 111.8 ± 12.7 113.2 ± 12.6 0.61
PHQ-9 score 12.3 ± 2.3 13.1 ± 3.0 0.14
 10–14 (moderate depression), n (%) 30 (88.0) 51 (70.8) 0.13
 15–19 (moderately severe depression), n (%) 3 (8.8) 18 (25.0)
 ≥20 (severe depression), n (%) 1 (2.9) 3 (4.2)
SCL-20 score 1.0 ± 0.7 1.3 ± 0.6 0.013
GAD-7 score 5.0 ± 4.0 7.9 ± 4.9 0.0043
 0–4 (minimal anxiety), n (%) 15 (44.1) 28 (38.9) 0.08
 5–9 (mild anxiety), n (%) 15 (44.1) 19 (26.4)
 10–14 (moderate anxiety), n (%) 3 (8.8) 20 (27.8)
 15–21 (severe anxiety), n (%) 1 (2.9) 5 (6.9)
Current use of ADM, n (%) 2 (5.9) 17 (23.6) 0.033
SBP, mmHg 124.2 ± 17.9 121.8 ± 16.4 0.49
DBP, mmHg 78.9 ± 14.4 76.2 ± 8.9 0.31
DASH score 1.6 ± 0.9 1.6 ± 1 0.95
Intake of fruit and vegetable, servings/d 2.5 ± 2.0 3.1 ± 1.9 0.13
Total fat, g/d 67.6 ± 20.5 73.4 ± 34.7 0.28
Energy intake, kilocalories/d 1658.0 ± 550.9 1721.8 ± 720.1 0.65

ADM, antidepressant medication; DBP, diastolic blood pressure; GAD-7, Generalized Anxiety Disorder 7-Item Scale; GED, general educational development; P, P value; PHQ-9, Patient Health Questionnaire-9; SBP, systolic blood pressure; SCL-20, Depression Symptom Checklist-20.

1

Values are mean ± SD unless noted otherwise.

2

Prognostic factors for randomization: age, sex, and treatment group.

3

Indicate P values <0.05.